SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: LT2011 who wrote (11352)6/22/2012 12:54:59 PM
From: NOREG3 Recommendations  Read Replies (1) | Respond to of 13111
 
The concern I've been voicing all along - very strange - almost as if we were in a quiet period. Even the Aussies aren't doing any thing despite the successful trial down there with the fantastic OR of 60% a long time ago and there has been all the other "good" news like Bystander Effects, Liver trials etc. Here we sit at 86 cents - it doesn't add up.



To: LT2011 who wrote (11352)6/22/2012 4:14:08 PM
From: LurkeyTurkey2 Recommendations  Read Replies (1) | Respond to of 13111
 
I've been sitting here wondering the exact same thing myself. Not one peep from Germany on this oh so important presentation.

Typical, IMO, for this company.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News